Analysis of a Switch From Enfuvirtide to Raltegravir in Patients with Undetectable Viral Load: Efficacy and Quality of Life at 24 Weeks. Journal of the International Association of Physicians in AIDS Care, 8(2): 85-86.

In by AHF

Phase 2 Gene Therapy Trial of an Anti-HIV Ribozyme in Autologous CD34+ Cells. Nature Medicine, 15: 285-292.
Phase 2 Gene Therapy Trial of an Anti-HIV Ribozyme in Autologous CD34+ Cells. Nature, 15: 285-292.
Download
File Type: pdf
File Size: 1 MB
Categories: 2009
Tags: 1999-2009
Author: Chien C, Easley A, Hamwi G, Hershey-Weber J, Khanlou H, Nguyen T, Prosser P, Ricaurte JC, Sanchez S, Sayana S, Wilson L